Global Antibody Market Analysis and Forecast 2024-2030

Global Antibody Market Analysis and Forecast 2024-2030


Summary

Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called “antigens”). The technology behind the generation of monoclonal antibodies was discovered in 1972 by César Milstein and Georges Köhler – scientists at the Roche-funded Basel Institute for Immunology – who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.

According to APO Research, The global Antibody market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Antibody is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Antibody is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Antibody is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Antibody is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Antibody include Roche, Johnson and Johnson, Merck, Novartis, AbbVie, Amgen, Pfizer, Bayer and Lilly, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Antibody, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Antibody, also provides the sales of main regions and countries. Of the upcoming market potential for Antibody, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Antibody sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Antibody market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Antibody sales, projected growth trends, production technology, application and end-user industry.

Antibody segment by Company

Roche
Johnson and Johnson
Merck
Novartis
AbbVie
Amgen
Pfizer
Bayer
Lilly
Bristol-Myers Squibb
GlaxoSmithKline
Biogen
AstraZeneca
Sanofi
Alexion Pharmaceuticals
Seattle Genetics
Antibody segment by Type

IgM
IgG
IgA
Other
Antibody segment by Application

Therapeutic
Research
Diagnostic
Antibody segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antibody market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Antibody and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antibody.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Antibody in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Antibody manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Antibody sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.


1 Market Overview
1.1 Product Definition
1.2 Antibody Market by Type
1.2.1 Global Antibody Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 IgM
1.2.3 IgG
1.2.4 IgA
1.2.5 Other
1.3 Antibody Market by Application
1.3.1 Global Antibody Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Therapeutic
1.3.3 Research
1.3.4 Diagnostic
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Antibody Market Dynamics
2.1 Antibody Industry Trends
2.2 Antibody Industry Drivers
2.3 Antibody Industry Opportunities and Challenges
2.4 Antibody Industry Restraints
3 Global Market Growth Prospects
3.1 Global Antibody Revenue Estimates and Forecasts (2019-2030)
3.2 Global Antibody Revenue by Region
3.2.1 Global Antibody Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Antibody Revenue by Region (2019-2024)
3.2.3 Global Antibody Revenue by Region (2025-2030)
3.2.4 Global Antibody Revenue Market Share by Region (2019-2030)
3.3 Global Antibody Sales Estimates and Forecasts 2019-2030
3.4 Global Antibody Sales by Region
3.4.1 Global Antibody Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Antibody Sales by Region (2019-2024)
3.4.3 Global Antibody Sales by Region (2025-2030)
3.4.4 Global Antibody Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 Market Competitive Landscape by Manufacturers
4.1 Global Antibody Revenue by Manufacturers
4.1.1 Global Antibody Revenue by Manufacturers (2019-2024)
4.1.2 Global Antibody Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Antibody Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Antibody Sales by Manufacturers
4.2.1 Global Antibody Sales by Manufacturers (2019-2024)
4.2.2 Global Antibody Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Antibody Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Antibody Sales Price by Manufacturers (2019-2024)
4.4 Global Antibody Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Antibody Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Antibody Manufacturers, Product Type & Application
4.7 Global Antibody Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Antibody Market CR5 and HHI
4.8.2 2023 Antibody Tier 1, Tier 2, and Tier 3
5 Antibody Market by Type
5.1 Global Antibody Revenue by Type
5.1.1 Global Antibody Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Antibody Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Antibody Revenue Market Share by Type (2019-2030)
5.2 Global Antibody Sales by Type
5.2.1 Global Antibody Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Antibody Sales by Type (2019-2030) & (KG)
5.2.3 Global Antibody Sales Market Share by Type (2019-2030)
5.3 Global Antibody Price by Type
6 Antibody Market by Application
6.1 Global Antibody Revenue by Application
6.1.1 Global Antibody Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Antibody Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Antibody Revenue Market Share by Application (2019-2030)
6.2 Global Antibody Sales by Application
6.2.1 Global Antibody Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Antibody Sales by Application (2019-2030) & (KG)
6.2.3 Global Antibody Sales Market Share by Application (2019-2030)
6.3 Global Antibody Price by Application
7 Company Profiles
7.1 Roche
7.1.1 Roche Comapny Information
7.1.2 Roche Business Overview
7.1.3 Roche Antibody Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Roche Antibody Product Portfolio
7.1.5 Roche Recent Developments
7.2 Johnson and Johnson
7.2.1 Johnson and Johnson Comapny Information
7.2.2 Johnson and Johnson Business Overview
7.2.3 Johnson and Johnson Antibody Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 Johnson and Johnson Antibody Product Portfolio
7.2.5 Johnson and Johnson Recent Developments
7.3 Merck
7.3.1 Merck Comapny Information
7.3.2 Merck Business Overview
7.3.3 Merck Antibody Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 Merck Antibody Product Portfolio
7.3.5 Merck Recent Developments
7.4 Novartis
7.4.1 Novartis Comapny Information
7.4.2 Novartis Business Overview
7.4.3 Novartis Antibody Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 Novartis Antibody Product Portfolio
7.4.5 Novartis Recent Developments
7.5 AbbVie
7.5.1 AbbVie Comapny Information
7.5.2 AbbVie Business Overview
7.5.3 AbbVie Antibody Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 AbbVie Antibody Product Portfolio
7.5.5 AbbVie Recent Developments
7.6 Amgen
7.6.1 Amgen Comapny Information
7.6.2 Amgen Business Overview
7.6.3 Amgen Antibody Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 Amgen Antibody Product Portfolio
7.6.5 Amgen Recent Developments
7.7 Pfizer
7.7.1 Pfizer Comapny Information
7.7.2 Pfizer Business Overview
7.7.3 Pfizer Antibody Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 Pfizer Antibody Product Portfolio
7.7.5 Pfizer Recent Developments
7.8 Bayer
7.8.1 Bayer Comapny Information
7.8.2 Bayer Business Overview
7.8.3 Bayer Antibody Sales, Revenue, Price and Gross Margin (2019-2024)
7.8.4 Bayer Antibody Product Portfolio
7.8.5 Bayer Recent Developments
7.9 Lilly
7.9.1 Lilly Comapny Information
7.9.2 Lilly Business Overview
7.9.3 Lilly Antibody Sales, Revenue, Price and Gross Margin (2019-2024)
7.9.4 Lilly Antibody Product Portfolio
7.9.5 Lilly Recent Developments
7.10 Bristol-Myers Squibb
7.10.1 Bristol-Myers Squibb Comapny Information
7.10.2 Bristol-Myers Squibb Business Overview
7.10.3 Bristol-Myers Squibb Antibody Sales, Revenue, Price and Gross Margin (2019-2024)
7.10.4 Bristol-Myers Squibb Antibody Product Portfolio
7.10.5 Bristol-Myers Squibb Recent Developments
7.11 GlaxoSmithKline
7.11.1 GlaxoSmithKline Comapny Information
7.11.2 GlaxoSmithKline Business Overview
7.11.3 GlaxoSmithKline Antibody Sales, Revenue, Price and Gross Margin (2019-2024)
7.11.4 GlaxoSmithKline Antibody Product Portfolio
7.11.5 GlaxoSmithKline Recent Developments
7.12 Biogen
7.12.1 Biogen Comapny Information
7.12.2 Biogen Business Overview
7.12.3 Biogen Antibody Sales, Revenue, Price and Gross Margin (2019-2024)
7.12.4 Biogen Antibody Product Portfolio
7.12.5 Biogen Recent Developments
7.13 AstraZeneca
7.13.1 AstraZeneca Comapny Information
7.13.2 AstraZeneca Business Overview
7.13.3 AstraZeneca Antibody Sales, Revenue, Price and Gross Margin (2019-2024)
7.13.4 AstraZeneca Antibody Product Portfolio
7.13.5 AstraZeneca Recent Developments
7.14 Sanofi
7.14.1 Sanofi Comapny Information
7.14.2 Sanofi Business Overview
7.14.3 Sanofi Antibody Sales, Revenue, Price and Gross Margin (2019-2024)
7.14.4 Sanofi Antibody Product Portfolio
7.14.5 Sanofi Recent Developments
7.15 Alexion Pharmaceuticals
7.15.1 Alexion Pharmaceuticals Comapny Information
7.15.2 Alexion Pharmaceuticals Business Overview
7.15.3 Alexion Pharmaceuticals Antibody Sales, Revenue, Price and Gross Margin (2019-2024)
7.15.4 Alexion Pharmaceuticals Antibody Product Portfolio
7.15.5 Alexion Pharmaceuticals Recent Developments
7.16 Seattle Genetics
7.16.1 Seattle Genetics Comapny Information
7.16.2 Seattle Genetics Business Overview
7.16.3 Seattle Genetics Antibody Sales, Revenue, Price and Gross Margin (2019-2024)
7.16.4 Seattle Genetics Antibody Product Portfolio
7.16.5 Seattle Genetics Recent Developments
8 North America
8.1 North America Antibody Market Size by Type
8.1.1 North America Antibody Revenue by Type (2019-2030)
8.1.2 North America Antibody Sales by Type (2019-2030)
8.1.3 North America Antibody Price by Type (2019-2030)
8.2 North America Antibody Market Size by Application
8.2.1 North America Antibody Revenue by Application (2019-2030)
8.2.2 North America Antibody Sales by Application (2019-2030)
8.2.3 North America Antibody Price by Application (2019-2030)
8.3 North America Antibody Market Size by Country
8.3.1 North America Antibody Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Antibody Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Antibody Price by Country (2019-2030)
8.3.4 U.S.
8.3.5 Canada
9 Europe
9.1 Europe Antibody Market Size by Type
9.1.1 Europe Antibody Revenue by Type (2019-2030)
9.1.2 Europe Antibody Sales by Type (2019-2030)
9.1.3 Europe Antibody Price by Type (2019-2030)
9.2 Europe Antibody Market Size by Application
9.2.1 Europe Antibody Revenue by Application (2019-2030)
9.2.2 Europe Antibody Sales by Application (2019-2030)
9.2.3 Europe Antibody Price by Application (2019-2030)
9.3 Europe Antibody Market Size by Country
9.3.1 Europe Antibody Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Antibody Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Antibody Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 China
10.1 China Antibody Market Size by Type
10.1.1 China Antibody Revenue by Type (2019-2030)
10.1.2 China Antibody Sales by Type (2019-2030)
10.1.3 China Antibody Price by Type (2019-2030)
10.2 China Antibody Market Size by Application
10.2.1 China Antibody Revenue by Application (2019-2030)
10.2.2 China Antibody Sales by Application (2019-2030)
10.2.3 China Antibody Price by Application (2019-2030)
11 Asia (Excluding China)
11.1 Asia Antibody Market Size by Type
11.1.1 Asia Antibody Revenue by Type (2019-2030)
11.1.2 Asia Antibody Sales by Type (2019-2030)
11.1.3 Asia Antibody Price by Type (2019-2030)
11.2 Asia Antibody Market Size by Application
11.2.1 Asia Antibody Revenue by Application (2019-2030)
11.2.2 Asia Antibody Sales by Application (2019-2030)
11.2.3 Asia Antibody Price by Application (2019-2030)
11.3 Asia Antibody Market Size by Country
11.3.1 Asia Antibody Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Antibody Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Antibody Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 Middle East, Africa and Latin America
12.1 MEALA Antibody Market Size by Type
12.1.1 MEALA Antibody Revenue by Type (2019-2030)
12.1.2 MEALA Antibody Sales by Type (2019-2030)
12.1.3 MEALA Antibody Price by Type (2019-2030)
12.2 MEALA Antibody Market Size by Application
12.2.1 MEALA Antibody Revenue by Application (2019-2030)
12.2.2 MEALA Antibody Sales by Application (2019-2030)
12.2.3 MEALA Antibody Price by Application (2019-2030)
12.3 MEALA Antibody Market Size by Country
12.3.1 MEALA Antibody Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Antibody Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Antibody Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 Value Chain and Sales Channels Analysis
13.1 Antibody Value Chain Analysis
13.1.1 Antibody Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Antibody Production Mode & Process
13.2 Antibody Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Antibody Distributors
13.2.3 Antibody Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings